|
Feb 2
|
Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands
|
|
Feb 2
|
This Weight Loss Stock Could Soar Over 220%, According to Wall Street. Time to Buy?
|
|
Feb 2
|
What To Expect in the Markets This Week
|
|
Feb 1
|
Want $1 Million in Retirement? 2 Stocks to Buy Now and Hold for Decades.
|
|
Feb 1
|
Tariffs, Amazon earnings, Jobs data: What to Watch next week
|
|
Jan 31
|
Pharma Stock Roundup: SNY and RHHBY's Q4 Earnings & More
|
|
Jan 31
|
Stocks to watch next week: Amazon, Palantir, Disney, Novo Nordisk and AstraZeneca
|
|
Jan 31
|
Novo Nordisk Shares Have a Long Road Back from 40% Slump
|
|
Jan 31
|
Billionaire Philippe Laffont Just Sold Top Artificial Intelligence Stocks Nvidia and AMD and Piled Into 2 Players Dominating Another High-Growth Billion-Dollar Industry
|
|
Jan 31
|
A cautionary tale that Europe can’t afford to ignore
|
|
Jan 30
|
Novo Nordisk A/S (NVO): A Bull Case Theory
|
|
Jan 30
|
Jim Cramer on Novo Nordisk A/S (NVO): ‘They Don’t Have The Production Capability’
|
|
Jan 29
|
Why Novo Nordisk (NVO) Dipped More Than Broader Market Today
|
|
Jan 29
|
Why Novo Nordisk A/S (NVO) Is the Best Blue Chip Stock to Buy Under $100?
|
|
Jan 29
|
Jim Cramer Says Novo Nordisk A/S (NVO) Is ‘Down So Much’
|
|
Jan 29
|
AKRO Stock Doubles in a Week as Lead Drug Meets Goal in MASH Study
|
|
Jan 29
|
Novo Nordisk secures FDA approval for Ozempic in diabetes with CKD
|
|
Jan 29
|
5 Monster Stocks to Hold for the Next 10 Years
|
|
Jan 28
|
Ozempic's FDA Approval Just Sent Shockwaves Through the Kidney Disease Market
|
|
Jan 28
|
How to Play NVO Stock After New Drug's Success in Obesity Study
|